search
Back to results

COPE for Children With Asthma: Intervention for Children With Asthma

Primary Purpose

Childhood Asthma, Childhood Anxiety Disorder, Childhood Depression

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
COPE for Asthma
Sponsored by
Ohio State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Childhood Asthma focused on measuring Childhood Asthma, Childhood Anxiety, Childhood Depression, Childhood Quality of Life

Eligibility Criteria

8 Years - 12 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Children age 8-12 years enrolled in Columbus City Schools
  • Diagnosis of persistent asthma requiring daily inhaled controller medication use at some point (medical condition form on file with the school/CG report)
  • Have symptoms depression or anxiety per the PROMIS/SCARED measures
  • Have written consent to participate provided by care giver and child assent
  • The participating care giver has primary or at least equal responsibility for the day-to-day management of the child's asthma
  • care givers provide written consent for their own participation
  • Be able to speak, read, and write in English (care giver and child).

Exclusion Criteria:

  • has other significant pulmonary conditions (e.g., pulmonary fibrosis, cystic fibrosis)
  • currently receiving treatment from a mental health professional
  • child or CG has cognitive learning disability that could interfere with the ability to comprehend the interview questions.

Sites / Locations

  • Columbus City Schools

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Intervention

Arm Description

This pre-experimental pilot project is a single group, pretest-posttest design with a 6-week post-intervention follow-up. A single group design was chosen for this feasibility pilot study because the COPE for Asthma intervention is newly adapted for 8 to 12-year-old children with asthma in an urban setting. The intervention will consist of 7 weekly sessions (30 minutes each). COPE for Asthma is a manualized, cognitive behavior skills-building intervention to improve the physical and mental health outcomes of children with asthma and elevated symptoms of anxiety or depression. Surveys with children and their parents/caregivers (CGs) will occur at baseline, immediately post-intervention and 6 weeks' post-intervention.

Outcomes

Primary Outcome Measures

Measure change in perception of asthma self-management over three time points
Asthma Management Self-Efficacy: The Child ASE scale (14 items) measures children's perception of their own ability to manage asthma (e.g., "...can tell when a serious breathing problem can be controlled at home"); assesses asthma symptoms, health status, and impact of the child's illness on the family. Higher scores indicate greater self-efficacy; (α=.87). This measure has been validated in children ages 7 - 15 years.

Secondary Outcome Measures

Measure change in anxiety symptoms over three time points
Anxiety Symptoms: SCARED (Screen for Child Anxiety Related Emotional Disorders) assesses five factors including panic/somatic, general anxiety disorder, separation anxiety, social phobia, and school phobia; it has been validated with children and adolescents ages 8 - 19 years. Items are scored from 0 (not true or hardly ever true) to 2 (very true or often true). Higher scores indicate greater anxiety with a total score of 25 as having a potential anxiety disorder and 30 as more specific (α=.70 - .90).
Measure change in depressive symptoms over three time points
Depressive Symptoms: PROMIS Pediatric Short Form: Assesses negative mood (e.g., sadness), decrease in positive affect (e.g., loss of interest), negative views of self (e.g., worthlessness), and negative social cognition (e.g., loneliness, interpersonal alienation). Items are scored from 0 (never) to 4 (almost always). Higher scores indicate greater anxiety(α=.85). The PROMIS Pediatric Instruments are intended for children between the ages of 8 - 17 years.
Measure change in confidence in managing stress over three time points
Personal Beliefs Scale: Child Version: 10-item Likert-type scale with items scored from 1 (strongly disagree) to 5 (strongly agree); assesses personal beliefs and confidence about managing stress. Higher scores indicate greater beliefs (α=.85). This scale has been used in prior studies for children and youth between the ages of 9 - 18 years.
Measure change in symptom interpretation over three time points
Symptom Interpretation: Childhood Asthma Symptom Checklist (CASCL): Interpretation of symptoms; 20-item measure of the frequency that children experience physical symptoms, irritability, and panic-fear during asthma attacks.191 Items are scored on a 4-point scale from 1 (never) to 4 (always). In addition to the three subscales the instrument yields a total symptom score (α=.81). This measure has been validated for children between the ages of 6 - 18 years.
Measure change in barriers to controller medications over three time points
Asthma Illness Representation Scale (AIRS-C): Child Version: The 17-item AIRS Child (AIRS-C) was designed to identify barriers and risk factors for under-utilization of controller medications. Higher scores indicate closer alignment with the professional model for asthma management. This scale has been adapted from the validated parent version and was tested in a small pilot study with acceptable reliability(α=.84). It has been validated for children between the ages of 6 - 17 years.
Measure change in quality of life over three time points
Pediatric Asthma Quality of Life Questionnaire (PAQLQ): 14-item Likert-type scale validated for children between ages 7 - 17 years; measures the functional problems (symptoms, activity limitations, emotional function) that are troublesome to children with asthma.31 Items are scored from 1 (extremely bothered) to 7 (not bothered at all) and the total score is the mean of items. Higher scores denote better QoL.
Measure change in asthma control over three time points
Asthma control: The Childhood Asthma Control Test (C-ACT) consists of questions for children (ages 4-11 years; 4 items) and parents (3 items) and the ACT (for individuals 12 years and older) has similar questions which are self-administered. This instruments assesses interference with activities, asthma symptoms, and nighttime awakenings. The C-ACT (α=.79) exhibits good reliability and validity, and classifies children as very poorly controlled, not well-controlled, or well controlled.
Measure comprehension over each lesson
Education Manipulation Checks: 4 (ordinal) questions will be asked after each session to evaluate children's comprehension of session content. Answering 3 out of 4 questions correctly indicates understanding. The Interventionist will review the incorrect questions and provide re-education for that item. These questions are age appropriate questions in line with the manual.

Full Information

First Posted
November 20, 2017
Last Updated
August 20, 2018
Sponsor
Ohio State University
Collaborators
American Nurses Foundation, Sigma Theta Tau International Honor Society of Nursing, National Association of Pediatric Nurse Practitioners, Sigma Theta Tau Epsilon Branch
search

1. Study Identification

Unique Protocol Identification Number
NCT03481673
Brief Title
COPE for Children With Asthma: Intervention for Children With Asthma
Official Title
COPE for Children With Asthma: A Cognitive Behavior Skills-Building
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
July 15, 2017 (Actual)
Primary Completion Date
May 21, 2018 (Actual)
Study Completion Date
May 21, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ohio State University
Collaborators
American Nurses Foundation, Sigma Theta Tau International Honor Society of Nursing, National Association of Pediatric Nurse Practitioners, Sigma Theta Tau Epsilon Branch

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Children with a chronic condition are at a significantly higher risk for anxiety and depression than those without a chronic condition. Asthma is the most common childhood chronic condition. Children with asthma and co-morbid anxiety and/or depression are at risk of poor health outcomes. The purpose of this study is to evaluate the effects of a manualized cognitive behavior skills-building intervention on key physical and mental health outcomes in 8 to 12-year old children with persistent asthma and co-morbid anxiety and/or depression. The results of this study will inform a large scale randomized controlled trial to fully test this needed intervention. COPE (Creating Opportunities for Personal Empowerment), developed by Dr. Melnyk, is a manualized intervention that has been implemented with children, adolescents, and young adults. COPE is a cognitive behavior skills-building program based on cognitive behavior theory. Results from previous studies using COPE have shown consistent decreases in anxiety and depression as well as an increase in healthy lifestyle behaviors in youth with elevated anxiety and depressive symptoms in inner city and rural settings, youth with obesity, and teens experiencing chronic recurrent headaches. However, the COPE program has never been adapted and tested with children who have persistent asthma. This study proposes to test an adaptation of this evidence-based program, "COPE for Asthma," with 8 to 12-year-old children with persistent asthma and elevated anxiety and/or depressive symptoms. COPE for Asthma combines components of asthma education with cognitive behavioral skills. This novel adaptation could fill a gap in research by providing a scalable intervention for this highly vulnerable population.
Detailed Description
The Interventionist was trained on the implementation of the COPE intervention and will deliver the COPE for Asthma intervention. The intervention, delivered by Colleen McGovern -the Interventionist, will take place in a room within the school separate from other students. The room will include a door for privacy. The intervention will be once/week, 30 minute sessions, for 7 weeks - during lunch and/or recess time. Groups during lunch and recess, or "lunch bunch" groups, are routinely held in the school system by the social workers, guidance counselors, and school nurses. Participants will be given weekly tickets allowing them to get in line first to pick up their lunch to maximize the allotted time. If the material for a session is not covered (i.e., school-wide fire drill, lock down, or other unforeseen event), the session will be moved to the following week. In the event a participant has severely elevated t-scores, >=70, on the anxiety or depression screening tools or expresses feelings or intent to harm self or others (at any time point or otherwise), the principal, school nurse and/or guidance counselor/social worker will be notified for follow-up per the school district's protocol. A form letter will be sent to the child's CG that day. If child discloses accounts of abuse or neglect, Franklin County Children's Services will be notified and the principal, school nurse and/or guidance counselor/social worker. Consent/assent of the CG and child and initial screening for anxiety/depression:SCARED and PROMIS measures; will be completed by the Interventionist and a research assistant, RA, from Dr. Melnyk's research team. Data collection and the intervention will start when >=5 child/CG dyads have been consented/assented in a school. Week 1 at baseline. To avoid bias, the Interventionist will serve as the interventionist and the RA will complete the data gathering. The measures for the child participants will be explained, then self-administered, and checked for completeness by the RA. The RA will conduct phone interviews with the CGs to gather data on demographics, controller medication adherence, and the Asthma Control Test. If phone contact is not possible, the surveys will be sent home with the child with sealable envelopes for the return. Weeks 2 - 8. COPE for Asthma will be delivered in small groups (Interventionist may need to implement the intervention at several schools on different days; this is expected). Lessons include 30 minutes of didactic teaching and activities. Post-Intervention Assessment, after the 7-week intervention. After the last COPE for Asthma session has been implemented in a group, a member of Dr. Melnyk's research team will administer the post-intervention follow-up surveys. CGs will be contacted to complete the parent/CG survey. 6-Week Post-Intervention Assessment. The same procedure as for the post-intervention assessment will be conducted for this time period for the children and CGs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Childhood Asthma, Childhood Anxiety Disorder, Childhood Depression
Keywords
Childhood Asthma, Childhood Anxiety, Childhood Depression, Childhood Quality of Life

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Single group, pre-experimental, intervention pilot study.
Masking
None (Open Label)
Allocation
N/A
Enrollment
33 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
This pre-experimental pilot project is a single group, pretest-posttest design with a 6-week post-intervention follow-up. A single group design was chosen for this feasibility pilot study because the COPE for Asthma intervention is newly adapted for 8 to 12-year-old children with asthma in an urban setting. The intervention will consist of 7 weekly sessions (30 minutes each). COPE for Asthma is a manualized, cognitive behavior skills-building intervention to improve the physical and mental health outcomes of children with asthma and elevated symptoms of anxiety or depression. Surveys with children and their parents/caregivers (CGs) will occur at baseline, immediately post-intervention and 6 weeks' post-intervention.
Intervention Type
Behavioral
Intervention Name(s)
COPE for Asthma
Intervention Description
The intervention will consist of 7 weekly sessions (30 minutes each). COPE for Asthma is a manualized, cognitive behavior skills-building intervention to improve the physical and mental health outcomes of children with asthma and elevated symptoms of anxiety or depression.
Primary Outcome Measure Information:
Title
Measure change in perception of asthma self-management over three time points
Description
Asthma Management Self-Efficacy: The Child ASE scale (14 items) measures children's perception of their own ability to manage asthma (e.g., "...can tell when a serious breathing problem can be controlled at home"); assesses asthma symptoms, health status, and impact of the child's illness on the family. Higher scores indicate greater self-efficacy; (α=.87). This measure has been validated in children ages 7 - 15 years.
Time Frame
Baseline (week 1, before the intervention starts), post-intervention (week 8-9, after the 7-week intervention), and 6-weeks post-intervention (week 16-17).
Secondary Outcome Measure Information:
Title
Measure change in anxiety symptoms over three time points
Description
Anxiety Symptoms: SCARED (Screen for Child Anxiety Related Emotional Disorders) assesses five factors including panic/somatic, general anxiety disorder, separation anxiety, social phobia, and school phobia; it has been validated with children and adolescents ages 8 - 19 years. Items are scored from 0 (not true or hardly ever true) to 2 (very true or often true). Higher scores indicate greater anxiety with a total score of 25 as having a potential anxiety disorder and 30 as more specific (α=.70 - .90).
Time Frame
Baseline (before the intervention starts), post-intervention (after the 7-week intervention), and 6-weeks post-intervention.
Title
Measure change in depressive symptoms over three time points
Description
Depressive Symptoms: PROMIS Pediatric Short Form: Assesses negative mood (e.g., sadness), decrease in positive affect (e.g., loss of interest), negative views of self (e.g., worthlessness), and negative social cognition (e.g., loneliness, interpersonal alienation). Items are scored from 0 (never) to 4 (almost always). Higher scores indicate greater anxiety(α=.85). The PROMIS Pediatric Instruments are intended for children between the ages of 8 - 17 years.
Time Frame
Baseline (before the intervention starts), post-intervention (after the 7-week intervention), and 6-weeks post-intervention.
Title
Measure change in confidence in managing stress over three time points
Description
Personal Beliefs Scale: Child Version: 10-item Likert-type scale with items scored from 1 (strongly disagree) to 5 (strongly agree); assesses personal beliefs and confidence about managing stress. Higher scores indicate greater beliefs (α=.85). This scale has been used in prior studies for children and youth between the ages of 9 - 18 years.
Time Frame
Baseline (before the intervention starts), post-intervention (after the 7-week intervention), and 6-weeks post-intervention.
Title
Measure change in symptom interpretation over three time points
Description
Symptom Interpretation: Childhood Asthma Symptom Checklist (CASCL): Interpretation of symptoms; 20-item measure of the frequency that children experience physical symptoms, irritability, and panic-fear during asthma attacks.191 Items are scored on a 4-point scale from 1 (never) to 4 (always). In addition to the three subscales the instrument yields a total symptom score (α=.81). This measure has been validated for children between the ages of 6 - 18 years.
Time Frame
Baseline (before the intervention starts), post-intervention (after the 7-week intervention), and 6-weeks post-intervention.
Title
Measure change in barriers to controller medications over three time points
Description
Asthma Illness Representation Scale (AIRS-C): Child Version: The 17-item AIRS Child (AIRS-C) was designed to identify barriers and risk factors for under-utilization of controller medications. Higher scores indicate closer alignment with the professional model for asthma management. This scale has been adapted from the validated parent version and was tested in a small pilot study with acceptable reliability(α=.84). It has been validated for children between the ages of 6 - 17 years.
Time Frame
Baseline (before the intervention starts), post-intervention (after the 7-week intervention), and 6-weeks post-intervention.
Title
Measure change in quality of life over three time points
Description
Pediatric Asthma Quality of Life Questionnaire (PAQLQ): 14-item Likert-type scale validated for children between ages 7 - 17 years; measures the functional problems (symptoms, activity limitations, emotional function) that are troublesome to children with asthma.31 Items are scored from 1 (extremely bothered) to 7 (not bothered at all) and the total score is the mean of items. Higher scores denote better QoL.
Time Frame
Baseline (before the intervention starts), post-intervention (after the 7-week intervention), and 6-weeks post-intervention.
Title
Measure change in asthma control over three time points
Description
Asthma control: The Childhood Asthma Control Test (C-ACT) consists of questions for children (ages 4-11 years; 4 items) and parents (3 items) and the ACT (for individuals 12 years and older) has similar questions which are self-administered. This instruments assesses interference with activities, asthma symptoms, and nighttime awakenings. The C-ACT (α=.79) exhibits good reliability and validity, and classifies children as very poorly controlled, not well-controlled, or well controlled.
Time Frame
Baseline (before the intervention starts), post-intervention (after the 7-week intervention), and 6-weeks post-intervention.
Title
Measure comprehension over each lesson
Description
Education Manipulation Checks: 4 (ordinal) questions will be asked after each session to evaluate children's comprehension of session content. Answering 3 out of 4 questions correctly indicates understanding. The Interventionist will review the incorrect questions and provide re-education for that item. These questions are age appropriate questions in line with the manual.
Time Frame
Baseline (before the intervention starts), post-intervention (after the 7-week intervention), and 6-weeks post-intervention.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Children age 8-12 years enrolled in Columbus City Schools Diagnosis of persistent asthma requiring daily inhaled controller medication use at some point (medical condition form on file with the school/CG report) Have symptoms depression or anxiety per the PROMIS/SCARED measures Have written consent to participate provided by care giver and child assent The participating care giver has primary or at least equal responsibility for the day-to-day management of the child's asthma care givers provide written consent for their own participation Be able to speak, read, and write in English (care giver and child). Exclusion Criteria: has other significant pulmonary conditions (e.g., pulmonary fibrosis, cystic fibrosis) currently receiving treatment from a mental health professional child or CG has cognitive learning disability that could interfere with the ability to comprehend the interview questions.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Colleen McGovern, PhD(c)
Organizational Affiliation
Ohio State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Columbus City Schools
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26712860
Citation
Akinbami LJ, Simon AE, Rossen LM. Changing Trends in Asthma Prevalence Among Children. Pediatrics. 2016 Jan;137(1):1-7. doi: 10.1542/peds.2015-2354. Epub 2015 Dec 28.
Results Reference
background
Citation
2. Centers for Disease Control and Prevention. Healthy Schools; asthma and schools. 2015. Retrieved on 3-28-2016 from http://www.cdc.gov/healthyschools/asthma/index.htm
Results Reference
background
Citation
3. American Lung Association. Asthma and Children Fact Sheet. Retrieved on 4-1-2016 from http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/asthma/learn-about-asthma/asthma-children-facts-sheet.html
Results Reference
background
PubMed Identifier
24628526
Citation
Goodwin RD, Hottinger K, Pena L, Chacko A, Feldman J, Wamboldt MZ, Hoven C. Asthma and mental health among youth in high-risk service settings. J Asthma. 2014 Aug;51(6):639-44. doi: 10.3109/02770903.2014.897728. Epub 2014 Mar 18.
Results Reference
background
PubMed Identifier
22957535
Citation
Lu Y, Mak KK, van Bever HP, Ng TP, Mak A, Ho RC. Prevalence of anxiety and depressive symptoms in adolescents with asthma: a meta-analysis and meta-regression. Pediatr Allergy Immunol. 2012 Dec;23(8):707-15. doi: 10.1111/pai.12000. Epub 2012 Sep 9.
Results Reference
background
PubMed Identifier
4021061
Citation
Strunk RC, Mrazek DA, Fuhrmann GS, LaBrecque JF. Physiologic and psychological characteristics associated with deaths due to asthma in childhood. A case-controlled study. JAMA. 1985 Sep 6;254(9):1193-8.
Results Reference
background
PubMed Identifier
16844893
Citation
Feldman JM, Ortega AN, McQuaid EL, Canino G. Comorbidity between asthma attacks and internalizing disorders among Puerto Rican children at one-year follow-up. Psychosomatics. 2006 Jul-Aug;47(4):333-9. doi: 10.1176/appi.psy.47.4.333.
Results Reference
background
PubMed Identifier
23171853
Citation
Goodwin RD, Robinson M, Sly PD, McKeague IW, Susser ES, Zubrick SR, Stanley FJ, Mattes E. Severity and persistence of asthma and mental health: a birth cohort study. Psychol Med. 2013 Jun;43(6):1313-22. doi: 10.1017/S0033291712001754. Epub 2012 Aug 29.
Results Reference
background
PubMed Identifier
16314605
Citation
Feldman JM, Siddique MI, Morales E, Kaminski B, Lu SE, Lehrer PM. Psychiatric disorders and asthma outcomes among high-risk inner-city patients. Psychosom Med. 2005 Nov-Dec;67(6):989-96. doi: 10.1097/01.psy.0000188556.97979.13.
Results Reference
background
PubMed Identifier
24730772
Citation
Al Aloola NA, Naik-Panvelkar P, Nissen L, Saini B. Asthma interventions in primary schools--a review. J Asthma. 2014 Oct;51(8):779-98. doi: 10.3109/02770903.2014.914534. Epub 2014 May 19.
Results Reference
background
PubMed Identifier
17186533
Citation
Yorke J, Fleming SL, Shuldham C. A systematic review of psychological interventions for children with asthma. Pediatr Pulmonol. 2007 Feb;42(2):114-24. doi: 10.1002/ppul.20464.
Results Reference
background
PubMed Identifier
23025250
Citation
Ritz T, Meuret AE, Trueba AF, Fritzsche A, von Leupoldt A. Psychosocial factors and behavioral medicine interventions in asthma. J Consult Clin Psychol. 2013 Apr;81(2):231-50. doi: 10.1037/a0030187. Epub 2012 Oct 1.
Results Reference
background
PubMed Identifier
23919906
Citation
Shanahan L, Copeland WE, Worthman CM, Angold A, Costello EJ. Children with both asthma and depression are at risk for heightened inflammation. J Pediatr. 2013 Nov;163(5):1443-7. doi: 10.1016/j.jpeds.2013.06.046. Epub 2013 Aug 3.
Results Reference
background
PubMed Identifier
22971065
Citation
Goodwin RD, Bandiera FC, Steinberg D, Ortega AN, Feldman JM. Asthma and mental health among youth: etiology, current knowledge and future directions. Expert Rev Respir Med. 2012 Aug;6(4):397-406. doi: 10.1586/ers.12.34.
Results Reference
background
PubMed Identifier
23154987
Citation
Feldman JM, Kutner H, Matte L, Lupkin M, Steinberg D, Sidora-Arcoleo K, Serebrisky D, Warman K. Prediction of peak flow values followed by feedback improves perception of lung function and adherence to inhaled corticosteroids in children with asthma. Thorax. 2012 Dec;67(12):1040-5. doi: 10.1136/thoraxjnl-2012-201789.
Results Reference
background
PubMed Identifier
17825729
Citation
Melnyk BM, Small L, Morrison-Beedy D, Strasser A, Spath L, Kreipe R, Crean H, Jacobson D, Kelly S, O'Haver J. The COPE Healthy Lifestyles TEEN program: feasibility, preliminary efficacy, & lessons learned from an after school group intervention with overweight adolescents. J Pediatr Health Care. 2007 Sep-Oct;21(5):315-22. doi: 10.1016/j.pedhc.2007.02.009.
Results Reference
background
PubMed Identifier
27026664
Citation
Hoying J, Melnyk BM. COPE: A Pilot Study With Urban-Dwelling Minority Sixth-Grade Youth to Improve Physical Activity and Mental Health Outcomes. J Sch Nurs. 2016 Oct;32(5):347-56. doi: 10.1177/1059840516635713. Epub 2016 Mar 29.
Results Reference
background
PubMed Identifier
24050416
Citation
Melnyk BM, Jacobson D, Kelly S, Belyea M, Shaibi G, Small L, O'Haver J, Marsiglia FF. Promoting healthy lifestyles in high school adolescents: a randomized controlled trial. Am J Prev Med. 2013 Oct;45(4):407-15. doi: 10.1016/j.amepre.2013.05.013.
Results Reference
background
PubMed Identifier
23748156
Citation
Melnyk BM, Kelly S, Jacobson D, Belyea M, Shaibi G, Small L, O'Haver J, Marsiglia FF. The COPE healthy lifestyles TEEN randomized controlled trial with culturally diverse high school adolescents: baseline characteristics and methods. Contemp Clin Trials. 2013 Sep;36(1):41-53. doi: 10.1016/j.cct.2013.05.013. Epub 2013 Jun 5.
Results Reference
background
PubMed Identifier
25864433
Citation
Hoying J, Melnyk BM, Arcoleo K. Effects of the COPE Cognitive Behavioral Skills Building TEEN Program on the Healthy Lifestyle Behaviors and Mental Health of Appalachian Early Adolescents. J Pediatr Health Care. 2016 Jan-Feb;30(1):65-72. doi: 10.1016/j.pedhc.2015.02.005. Epub 2015 Apr 10.
Results Reference
background
PubMed Identifier
25801377
Citation
Kozlowski JL, Lusk P, Melnyk BM. Pediatric Nurse Practitioner Management of Child Anxiety in a Rural Primary Care Clinic With the Evidence-Based COPE Program. J Pediatr Health Care. 2015 May-Jun;29(3):274-82. doi: 10.1016/j.pedhc.2015.01.009. Epub 2015 Mar 20.
Results Reference
background
PubMed Identifier
26429638
Citation
Militello LK, Melnyk BM, Hekler E, Small L, Jacobson D. Correlates of Healthy Lifestyle Beliefs and Behaviors in Parents of Overweight or Obese Preschool Children Before and After a Cognitive Behavioral Therapy Intervention With Text Messaging. J Pediatr Health Care. 2016 May-Jun;30(3):252-60. doi: 10.1016/j.pedhc.2015.08.002. Epub 2015 Oct 1.
Results Reference
background
PubMed Identifier
23511090
Citation
Small L, Bonds-McClain D, Melnyk B, Vaughan L, Gannon AM. The preliminary effects of a primary care-based randomized treatment trial with overweight and obese young children and their parents. J Pediatr Health Care. 2014 May-Jun;28(3):198-207. doi: 10.1016/j.pedhc.2013.01.003. Epub 2013 Mar 17.
Results Reference
background
PubMed Identifier
25017938
Citation
Hickman C, Jacobson D, Melnyk BM. Randomized controlled trial of the acceptability, feasibility, and preliminary effects of a cognitive behavioral skills building intervention in adolescents with chronic daily headaches: a pilot study. J Pediatr Health Care. 2015 Jan-Feb;29(1):5-16. doi: 10.1016/j.pedhc.2014.05.001. Epub 2014 Jul 10.
Results Reference
background
PubMed Identifier
19909421
Citation
Melnyk BM, Jacobson D, Kelly S, O'Haver J, Small L, Mays MZ. Improving the mental health, healthy lifestyle choices, and physical health of Hispanic adolescents: a randomized controlled pilot study. J Sch Health. 2009 Dec;79(12):575-84. doi: 10.1111/j.1746-1561.2009.00451.x.
Results Reference
background
Citation
26. Franklin County Public Health. Franklin County HealthMap2016. Retrieved on May 10, 2016 from http://www.myfcph.org/pdfs/hstat_FCHealthMap16.pdf
Results Reference
background
PubMed Identifier
10077141
Citation
Bursch B, Schwankovsky L, Gilbert J, Zeiger R. Construction and validation of four childhood asthma self-management scales: parent barriers, child and parent self-efficacy, and parent belief in treatment efficacy. J Asthma. 1999;36(1):115-28. doi: 10.3109/02770909909065155. Erratum In: J Asthma. 2011 May;48(4):427.
Results Reference
background
Citation
28. Assessment Center. PROMIS Scoring Manuals. Retrieved on May 10, 2016 from https://www.assessmentcenter.net/Manuals.aspx
Results Reference
background
PubMed Identifier
2734427
Citation
Fritz GK, Overholser JC. Patterns of response to childhood asthma. Psychosom Med. 1989 May-Jun;51(3):347-55. doi: 10.1097/00006842-198905000-00009.
Results Reference
background
PubMed Identifier
20528596
Citation
Sidora-Arcoleo KJ, Feldman J, Serebrisky D, Spray A. Validation of the Asthma Illness Representation Scale-Spanish (AIRS-S). J Asthma. 2010 May;47(4):417-21. doi: 10.3109/02770901003702832.
Results Reference
background
PubMed Identifier
8466117
Citation
Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993 Apr;147(4):832-8. doi: 10.1164/ajrccm/147.4.832.
Results Reference
background
PubMed Identifier
17353040
Citation
Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007 Apr;119(4):817-25. doi: 10.1016/j.jaci.2006.12.662. Epub 2007 Mar 13.
Results Reference
background
PubMed Identifier
20624640
Citation
Liu AH, Zeiger RS, Sorkness CA, Ostrom NK, Chipps BE, Rosa K, Watson ME, Kaplan MS, Meurer JR, Mahr TA, Blaiss MS, Piault-Louis E, McDonald J. The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. J Allergy Clin Immunol. 2010 Aug;126(2):267-73, 273.e1. doi: 10.1016/j.jaci.2010.05.031. Epub 2010 Jul 10.
Results Reference
background
Citation
34. Muthén L, Muthén B. Mplus user's guide. 1998-2012. Los Angeles, CA.
Results Reference
background
PubMed Identifier
27519444
Citation
Murphy JM, Bergmann P, Chiang C, Sturner R, Howard B, Abel MR, Jellinek M. The PSC-17: Subscale Scores, Reliability, and Factor Structure in a New National Sample. Pediatrics. 2016 Sep;138(3):e20160038. doi: 10.1542/peds.2016-0038. Epub 2016 Aug 12.
Results Reference
background
Citation
36. Wang M, Bodner TE. Growth Mixture Modeling Identifying and Predicting Unobserved Subpopulations With Longitudinal Data. Organizational Research Methods. 2007;10(4):635-656.
Results Reference
background
PubMed Identifier
22360932
Citation
Jacobson D, Melnyk BM. A primary care healthy choices intervention program for overweight and obese school-age children and their parents. J Pediatr Health Care. 2012 Mar;26(2):126-38. doi: 10.1016/j.pedhc.2010.07.004. Epub 2010 Aug 21.
Results Reference
background
PubMed Identifier
20100018
Citation
Sidora-Arcoleo K, Feldman J, Serebrisky D, Spray A. Validation of the Asthma Illness Representation Scale (AIRS). J Asthma. 2010 Feb;47(1):33-40. doi: 10.3109/02770900903362668.
Results Reference
background
PubMed Identifier
25642130
Citation
Beidas RS, Stewart RE, Walsh L, Lucas S, Downey MM, Jackson K, Fernandez T, Mandell DS. Free, brief, and validated: Standardized instruments for low-resource mental health settings. Cogn Behav Pract. 2015 Feb 1;22(1):5-19. doi: 10.1016/j.cbpra.2014.02.002.
Results Reference
background
PubMed Identifier
20662993
Citation
Hale WW 3rd, Crocetti E, Raaijmakers QA, Meeus WH. A meta-analysis of the cross-cultural psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED). J Child Psychol Psychiatry. 2011 Jan;52(1):80-90. doi: 10.1111/j.1469-7610.2010.02285.x.
Results Reference
background
PubMed Identifier
10517055
Citation
Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1230-6. doi: 10.1097/00004583-199910000-00011.
Results Reference
background
PubMed Identifier
34736820
Citation
McGovern CM, Hutson E, Arcoleo K, Melnyk B. Considerations in pediatric intervention research: Lessons learned from two pediatric pilot studies. J Pediatr Nurs. 2022 Mar-Apr;63:78-83. doi: 10.1016/j.pedn.2021.10.016. Epub 2021 Nov 1.
Results Reference
derived

Learn more about this trial

COPE for Children With Asthma: Intervention for Children With Asthma

We'll reach out to this number within 24 hrs